Early treatment in early undifferentiated arthritis

Autoimmunity Reviews

Volumn 11, Issue 8, 2012, Pages 589-592

  Olivieri, Ignazio ^a   Sarzi Puttini, Piercarlo ^b   Bugatti, Serena ^c   Atzeni, Fabiola ^b,d   d'Angelo, Salvatore ^a,e   Caporali, Roberto ^c  

^a San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF MOLISE   (Italy)

Author keywords

Early diagnosis; Rheumatoid arthritis; Treatment; Undifferentiated arthritis

Indexed keywords

GLUCOCORTICOID; METHOTREXATE; PLACEBO;

ARTHRITIS; CLINICAL PROTOCOL; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DISEASE COURSE; EARLY DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; HUMAN; LONG TERM CARE; MEDICAL HISTORY; MORTALITY; MUSCULOSKELETAL ULTRASONOGRAPHY; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; ITALY; PREVALENCE;

EID: 84861479912     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.10.019     Document Type: Review

References (42)

1. Combe B., Landewe R., Luckas C., Bolosiu H.D., Breedveld F., Dougados M., et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:34-45.
2. Nell V.P., Machold K.P., Eberl G., Stamm T.A., Uffmann K.P., Smolen J.S. Benefit of very early referral and very early therapy with disease modifying anti-rheumatic dugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:906-914.
3. Anderson J.J., Wells G., Verhoeven A.C., Felson D.T. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000, 43:22-29.
4. Bukhari M.A., Wiles N.J., Lunt M., Harrison B.J., Scott D.G., Simmons D.P., et al. Influence of disease modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum 2003, 48:46-53.
5. Finckl A., Liang M.H., van Herckenrode C.M., de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006, 55:864-872.
6. Arnett F.C., Edworthy S.M., Block D.A., McShane D.S., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
7. Banai F., Dougados M., Combescure C., Gossec L. Sensitivity and specificity of the American college of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis. Ann Rheum Dis 2009, 68:1184-1191.
8. Tunn E.J., Bacon P.A. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 1993, 32:97-103.
9. Harrison B.J., Symmons D.P., Brennan P., Barrett E.M., Silman A.J. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 1996, 35:1096-1100.
10. Visser H., le Cessie S., Vos K., Breedveld F.C., Hazes J.M. How to diagnose rheumatoid arthritis early: a prediction model for persistent erosive arthritis. Arthritis Rheum 2002, 46:357-365.
11. van Aken J., van Bilsen J.H., Allaart C.F., Huizinga T.W., Breedveld F.C. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003, 21:S100-S105.
12. Machould K.P., Nell V.P., Stamm T.A., Elberl G., Steiner G., Smolen J.S., et al. The Austrian Early Arthritis Registry. Clin Exp Rheumatol 2003, 21:S113-S117.
13. Quinn M.A., Green M.J., Marzo-Hortega H., Proudman S., Karim Z., Wakefield R.J., et al. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003, 48:3039-3045.
14. van Aken J., van Dongen H., le Cessie S., Allaart C.F., Breedveld F.C., Huizinga T.W. Comparison of long-term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 2006, 65:20-25.
15. Mjaavatten M.D., Haugen A.J., Helgetveit K., Nyqaard H., Sidenvall G., Uhlig T., et al. Pattern of joint involvement and other disease characteristics in 634 patients with arthritis of less than 16 weeks' duration. J Rheumatol 2009, 36:1401-1406.
16. de Rooy D.P., van der Linden M.P., Knevel R., Huizinga T.W., van der Helm-van Mil A.H. Predicting arthritis outcomes - what can be learned from the Leiden Early Arthritis Clinic?. Rheumatology 2011, 50:93-100.
17. Hazes J.M.W., Luime J.J. The epidemiology of early inflammatory arthritis. Nat Rev Rheumatol 2011, 7:381-390.
18. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581.
19. Alves C., Luime J.J., van Zeben D., Huisman A.M., Weel A.E., Barendregt P.J., et al. Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis 2011, 70:1645-1647.
20. Visser K., Allaart C.F., Huizinga T.W. Use of methotrexate in undifferentiated arthritis. Clin Exp Rheumatol 2010, 28(5 Suppl 61):S117-S121.
21. van der Helm-van Mil A.H., le Cessie S., van Dongen H., Breedveld F.C., Toes R.E., Huizinga T.W. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007, 56:433-440.
22. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
23. Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
24. Hayer S., Redlich K., Korb A., Hermann S., Smolen J., Schett G. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis. Arthritis Rheum 2007, 56:79-88.
25. Kraan M.C., Versendaal H., Jonker M., Bresnihan B., Post W.J., t Hart B.A., et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998, 41:1481-1488.
26. Tak P.P., Smeets T.J., Daha M.R., Kluin P.M., Meijers K.A., Brand R., et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997, 40:217-225.
27. Manzo A., Bombardieri M., Humby F., Pitzalis C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol Rev 2010, 233:267-285.
28. Proulx S.T., Kwok E., You Z., Papuga M.O., Beck C.A., Shealy D.J., et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum 2007, 56:4024-4037.
29. Manzo A., Caporali R., Vitolo B., Alessi S., Benaglio F., Todoerti M., et al. Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography. Rheumatology 2011, 50:1395-1400.
30. van Dongen H., van Aken J., Lard L.R., Visser K., Ronday H.K., Hulsmans H.M., et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007, 56:1424-1432.
31. Duer-Jensen A., Hørslev-Petersen K., Hetland M.L., Bak L., Ejbjerg B.J., Hansen M.S., et al. MRI bone edema is an independent predictor of development of rheumatoid arthritis in patients with early undifferentiated arthritis. Arthritis Rheum 2011, 63(8):2192-2202.
32. Bugatti S., Manzo A., Bombardieri M., Vitolo B., Humby F., Kelly S., et al. Synovial tissue heterogeneity and peripheral blood biomarkers. Curr Rheumatol Rep 2011, 13:440-448.
33. Machado P., Castrejon I., Katchamart W., Koevoets R., Kuriya B., Schoels M., et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2011, 70:15-24.
34. Machold K.P., Nell V.P., Stamm T.A., Smolen J.S. Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?. Arthritis Res Ther 2006, 8(3):211.
35. Bos W.H., Wolbink G.J., Boers M., Tijhuis G.J., de Vries N., van der Horst-Bruinsma I.E., et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010, 69:490-494.
36. Symmons D.P., Silman A.J. Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register. Arthritis Res Ther 2006, 8(4):214.
37. Machold K.P., Landewé R., Smolen J.S., Stamm T.A., van der Heijde D.M., et al. The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Ann Rheum Dis 2010, 69:495-502.
38. Verstappen S.M., McCoy M.J., Roberts C., Dale N.E., Hassell A.B., Symmons D.P., STIVEA investigators Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann Rheum Dis 2010, 69:503-509.
39. Emery P., Durez P., Dougados M., Legerton C.W., Becker J.C., Vratsanos G., et al. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial). Ann Rheum Dis 2010, 69:510-516.
40. Salaffi F., Ciapetti A., Gasparini S., Carotti M., Filippucci E., Grassi W. A clinical prediction rule combining routine assessment and power Doppler ultrasonography for predicting progression to rheumatoid arthritis from early-onset undifferentiated arthritis. Clin Exp Rheumatol 2010, 28:686-694.
41. Brown A.K. Using ultrasonography to facilitate best practice in diagnosis and management of RA. Nat Rev Rheumatol 2009, 5:698-706.
42. Suter L.G., Fraekel L., Braithwaite R.S. Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011, 63:675-688.